DESIGN, MEASURES, AND CORRELATES OF CHANGES IN AD BLOOD BIOMARKERS AND ASSOCIATIONS WITH NEUROIMAGING OUTCOMES

Abstract

Few studies have examined changes in blood-based biomarkers of AD pathology and neurodegeneration particularly during the mid- to late-life transition period and associations with brain pathology. Among 1525 (59.9% women, 25.